Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammasomes in Liver Fibrosis
Fernando Alegre, Pablo Pelegrı́n, Ariel E. Feldstein
Seminars in Liver Disease (2017) Vol. 37, Iss. 02, pp. 119-127
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1292
Triggering and resolution of inflammation in NASH
Susanne Schuster, Daniel Cabrera, Marco Arrese, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 6, pp. 349-364
Closed Access | Times Cited: 751
Apoptosis and necroptosis in the liver: a matter of life and death
Robert F. Schwabe, Tom Luedde
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 12, pp. 738-752
Open Access | Times Cited: 474
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis
Susanne Gaul, Aleksandra Leszczynska, Fernando Alegre, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 1, pp. 156-167
Open Access | Times Cited: 414
Biological responses to physicochemical properties of biomaterial surface
Maryam Rahmati, Eduardo A. Silva, Janne E. Reseland, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 15, pp. 5178-5224
Open Access | Times Cited: 256
Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation
Gaia Favero, Lorenzo Franceschetti, Francesca Bonomini, et al.
International Journal of Endocrinology (2017) Vol. 2017, pp. 1-13
Open Access | Times Cited: 210
Role of the Inflammasome in Liver Disease
Marcelle de Carvalho Ribeiro, Gyöngyi Szabó
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 345-365
Open Access | Times Cited: 187
Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature
Mikiko Watanabe, Rossella Tozzi, Renata Risi, et al.
Obesity Reviews (2020) Vol. 21, Iss. 8
Open Access | Times Cited: 185
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
Oliver Krenkel, Jana Hundertmark, Thomas Ritz, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 503-503
Open Access | Times Cited: 180
Immunological mechanisms and therapeutic targets of fatty liver diseases
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 157
Understanding the cellular interactome of non-alcoholic fatty liver disease
Sebastian Wallace, Frank Tacke, Robert F. Schwabe, et al.
JHEP Reports (2022) Vol. 4, Iss. 8, pp. 100524-100524
Open Access | Times Cited: 83
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101231-101231
Open Access | Times Cited: 70
Pyroptosis in Liver Disease: New Insights into Disease Mechanisms
Jiali Wu, Su Lin, Bo Wan, et al.
Aging and Disease (2019) Vol. 10, Iss. 5, pp. 1094-1094
Open Access | Times Cited: 132
Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis
Eun Hee Koh, Ji Eun Yoon, Myoung Seok Ko, et al.
Gut (2020) Vol. 70, Iss. 10, pp. 1954-1964
Open Access | Times Cited: 125
NLR Family Pyrin Domain‐Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice
María Eugenia Inzaugarat, Casey D. Johnson, Theresa Maria Holtmann, et al.
Hepatology (2018) Vol. 69, Iss. 2, pp. 845-859
Open Access | Times Cited: 117
Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome
Xueling Li, Jin Geng, Jinxuan Zhao, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 115
The inflammasome in host response to biomaterials: Bridging inflammation and tissue regeneration
Daniela P. Vasconcelos, Artur P. Águas, Mário A. Barbosa, et al.
Acta Biomaterialia (2018) Vol. 83, pp. 1-12
Closed Access | Times Cited: 101
Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress
Sabira Mohammed, Evan H. Nicklas, Nidheesh Thadathil, et al.
Free Radical Biology and Medicine (2021) Vol. 164, pp. 315-328
Open Access | Times Cited: 92
Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis
Kun Zhang, Zhemin Shi, Mengxia Zhang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 89
Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation
Wenhui Xie, Jian Ding, Xie Xiao-xia, et al.
Inflammation Research (2020) Vol. 69, Iss. 7, pp. 683-696
Open Access | Times Cited: 87
Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver
Qi Su, Sun Y. Kim, Funmi Adewale, et al.
iScience (2021) Vol. 24, Iss. 11, pp. 103233-103233
Open Access | Times Cited: 84
The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice
Junwen Qu, Zhiqing Yuan, Guiyang Wang, et al.
International Immunopharmacology (2019) Vol. 70, pp. 147-155
Closed Access | Times Cited: 80
Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI
Yuhua Chen, Jiao Meng, Quanhua Xu, et al.
Brain Research (2019) Vol. 1710, pp. 163-172
Closed Access | Times Cited: 79
MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury
Jianhang Jiao, Guanjie Zhao, Yang Wang, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 75
Macrophage‐specific FGF12 promotes liver fibrosis progression in mice
Santie Li, Bin Zhou, Mei Xue, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 816-833
Closed Access | Times Cited: 43
Page 1 - Next Page

Scroll to top